Vancomycin-intermediate Staphylococcus aureus in a home health-care patient

J C Hageman; D A Pegues; C Jepson; R L Bell; M Guinan; K W Ward; M D Cohen; J A Hindler; F C Tenover; S K McAllister; M E Kellum; S K Fridkin

doi:10.3201/eid0706.010618

Vancomycin-intermediate Staphylococcus aureus in a home health-care patient

Emerg Infect Dis. 2001 Nov-Dec;7(6):1023-5. doi: 10.3201/eid0706.010618.

Authors

J C Hageman¹, D A Pegues, C Jepson, R L Bell, M Guinan, K W Ward, M D Cohen, J A Hindler, F C Tenover, S K McAllister, M E Kellum, S K Fridkin

Affiliation

¹ Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. jhageman@cdc.gov

Abstract

In June 2000, vancomycin-intermediate Staphylococcus aureus (VISA) was isolated from a 27-year-old home health-care patient following a complicated cholecystectomy. Two VISA strains were identified with identical MICs to all antimicrobials tested except oxacillin and with closely related pulsed-field gel electrophoresis types. The patient was treated successfully with antimicrobial therapy, biliary drainage, and reconstruction. Standard precautions in the home health setting appear successful in preventing transmission.

Publication types

Case Reports

MeSH terms

Adult
Anti-Bacterial Agents / pharmacology*
DNA, Bacterial / analysis
Female
Home Care Services*
Humans
Infectious Disease Transmission, Patient-to-Professional
Microbial Sensitivity Tests
Nurses
Risk Factors
Staphylococcal Infections / microbiology*
Staphylococcal Infections / transmission
Staphylococcus aureus / drug effects
Staphylococcus aureus / genetics
Staphylococcus aureus / growth & development
Vancomycin / pharmacology*
Vancomycin Resistance* / genetics

Substances

Anti-Bacterial Agents
DNA, Bacterial
Vancomycin